Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NGM Biopharmaceuticals
Biotech
J&J vet jumps to Affinia—Chutes & Ladders
J&J vet jumps to Affinia. Astellas shakes up C-suite with exec firings. Pfizer builds oncology team with Legos.
Darren Incorvaia
,
Zoey Becker
Feb 7, 2025 8:30am
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
VC firm that took NGM private oversees biotech’s $122M series A
Jul 17, 2024 7:42am
NGM to go private as part of $135M buyout by VC firm Column
Feb 26, 2024 10:26am
NGM hunts for light at end of tunnel with NASH trial
May 5, 2023 1:13pm
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am